citrulline has been researched along with Bile Duct Obstruction in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Koivusalo, A; Lohi, J; Merras-Salmio, L; Mutanen, A; Pakarinen, MP | 1 |
Janusz, M; Jaworski, M; Kozlowski, D; Ksiazyk, J; Olszewska, K; Pajdowska, M | 1 |
Huijbers, A; Koelfat, KVK; Lenicek, M; Olde Damink, SWM; Schaap, FG; Soeters, MR; van Kuijk, SMJ; Wanten, GJA | 1 |
Chan, CF; Wu, TC | 1 |
1 review(s) available for citrulline and Bile Duct Obstruction
Article | Year |
---|---|
Recent advances in the management of pediatric intestinal failure.
Topics: Catheter-Related Infections; Child; Cholestasis; Citrulline; Digestive System Surgical Procedures; Humans; Intestinal Diseases; Parenteral Nutrition; Short Bowel Syndrome | 2014 |
3 other study(ies) available for citrulline and Bile Duct Obstruction
Article | Year |
---|---|
Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Cholestasis; Citrulline; Disease Progression; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Infant; Intestinal Failure; Liver; Liver Diseases; Male; Parenteral Nutrition; Prognosis; Prospective Studies; Retrospective Studies | 2021 |
Nutritional therapy complications in children with ultra-short bowel syndrome include growth deficiency but not cholestasis.
Topics: Adolescent; Bone Density; Child; Child, Preschool; Cholestasis; Citrulline; Cohort Studies; Female; Growth Disorders; Humans; Infant; Liver Function Tests; Male; Nutritional Status; Parenteral Nutrition, Home; Short Bowel Syndrome; Vitamin D | 2018 |
Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score).
Topics: Adult; Aged; Cholestasis; Chronic Disease; Citrulline; Female; Fibroblast Growth Factors; Humans; Intestinal Diseases; Male; Middle Aged; Prospective Studies; Retrospective Studies | 2019 |